An experimental model of small intestinal submucosa as a growing vascular graft  by Robotin-Johnson, Monica C. et al.
The small intestine has been tried as a vascular sub-
stitute as far back as 1965, but its efficacy proved very
variable in various experimental designs.2,3 Using only
its submucosa and the deep layers of the mucosal layer,
Lantz and coworkers4-6 obtained superior results when
replacing arterial and venous segments in different
experimental animals. Using their experience as a start-
ing point, we tested the hypothesis that the submucosa
of the small intestine could be used as a template that
would enable a vascular graft to grow sufficiently to
keep up with an animal’s somatic growth.
Material and methods
Eleven piglets, weighing between 8 and 14 kg, were used in
this study. All animals received humane care, in accordance
with the “Guide for the Care and Use of Laboratory Animals”
published by the National Institutes of Health (NIH Publication
No. 85-23, revised 1985). The research protocol was approved
by the Washington University Animal Care Committee.
T he search for an ideal vascular graft, suited to thepediatric population, has so far yielded disappoint-
ing results. As is true of any vascular substitute, the
graft should be biocompatible, resist degeneration and
infection, have good handling properties, and be avail-
able readily and in a range of sizes.1 In addition, growth
potential would be required ideally, to avoid repeat
operations as the child grows.
Objective: The ideal vascular graft for use in children with congenital
heart disease should not only be biocompatible and nonthrombogenic
and present no infectious risk, but ideally it should grow at the same
rate as the recipient. Methods: We have tested autologous small intestine
submucosa as a superior vena cava interposition graft in 11 piglets. The
grafts were prepared from segments of jejunum, rendered nonthrombo-
genic by heparin bonding. The superior vena cava from the level of the
azygos vein to the superior vena cava–right atrial junction was replaced. 
Results: One early and 1 late death were not related to the graft materi-
al. At 90 days, the weight of the 9 survivors increased by 630%, from a
mean of 10.3 ± 2.0 kg to a mean of 59.2 ± 16.7 kg (P < .001). The grafts
increased in circumference by 184%, from a mean of 36.8 ± 4.4 mm to a
mean of 61.4 ± 12.1 mm (P < .001) at late follow-up. Their length
increased by 147%, from a mean of 9.9 ± 2.1 mm at implantation to a
mean of 15.8 ± 5.5 mm at explantation (P = .002 ). At the time of explan-
tation, all 11 grafts were patent and free of thrombus. Cavograms
showed no anastomotic stricture or aneurysm formation in 7 of 9 cases.
The luminal surface of all grafts was smooth, shiny, and indistinguish-
able from that of the native cava. Light microscopy showed a loosely tex-
tured collagen framework, with a dense capillary network and complete
luminal coverage by a single, continuous cell layer displaying the ultra-
structural features characteristic of endothelial cells. Conclusion: Small
intestine submucosa provides a collagen framework that becomes
remodeled, grows, and acquires a nonthrombogenic endothelial lining.
This makes it potentially well suited as a cardiovascular substitute in
children. (J Thorac Cardiovasc Surg 1998;116:805-11)
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Four pigs, killed at the end of other experiments, with a
weight range similar to that of the 11 animals at the end of the
study, had measurements of their superior vena cava (SVC) at
the same points as the experimental group. They served as a
control group.
Surgical procedures and graft preparation. Anesthesia
was induced with sodium pentothal (30 mg/kg) and main-
tained with isoflurane and intermittent sodium pentothal
administration. A catheter was placed in the left femoral
artery to monitor blood pressure and obtain blood samples.
Harvest of small intestinal submucosa (SIS). A muscle-
sparing paramedian celiotomy was made, and a 5- to 8-cm
long segment of jejunum was excised. Intestinal continuity
was reestablished, using a 2-layer anastomotic technique. The
abdominal incision was closed in layers.
Preparation of the small intestine submucosa graft. The
resected intestinal segment was prepared for use as a vascu-
lar graft, according to the technique described by Lantz and
coworkers.5
In brief, the graft was inverted, and the mucosal layer was
removed by gentle abrasion; with the graft in its original ori-
entation, the intestinal serosa and the tunica muscularis were
delaminated, with the same technique. This left a translucent
graft material, consisting of intestinal submucosa, with
attached stratum compactum of the intestinal mucosa and the
muscularis mucosae (Fig 1, A). This has been termed small
intestinal submucosa (SIS) by previous investigators.5
Because the integrity of the stratum compactum appears
essential for the graft’s thromboresistance, a piece of each
graft was sent for histopathologic analysis to confirm the
accuracy of graft preparation.6
As in our previous experience, most grafts thrombosed
early, despite intravenous heparin administration; we used a
technique described by Miyata and coworkers,7 which enables
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Fig 1. A, Normal small bowel. At high magnification, the interface between submucosa and mucosa is defined
by a thin muscularis mucosa (mm) and an overlying delicate paucicellular fibrous band (stratum compactum [sc]).
The latter elements, together with the submucosa, comprise the graft material illustrated in B. (Hematoxylin and
eosin stain; original magnification · 500.) B, The submucosal graft. At a magnification comparable with A, the 3
elements of the graft are evident in a trichrome-stained preparation. The stratum compactum (sc), the darkly
stained muscularis mucosa (mm), and underlying collagenous submucosa (sm) are demonstrated. Note the vas-
culature of the submucosa. (Gomori trichromestain; original magnification · 500). C, Normal SVC. The cava is
lined by an intact endothelium (arrows) that is supported by a media (m) that is composed primarily of smooth
muscle. The adventitia (a) is formed of paucicellular, collagenous tissue. (Hematoxylin and eosin stain; original
magnification · 500.) D, The submucosal graft ex vivo. A thickened, fibrous, amuscular wall supports an intact,
low-cuboidal endothelium. The endothelial layer is taller than in normal cavae (compare with C), and the sup-
porting collagenous stroma is more cellular. (Hematoxylin and eosin stain; original magnification · 500).
heparin to bind to the exposed collagen fibrils and renders the
graft non-thrombogenic, while endothelialization occurs.
The graft was soaked in protamine sulfate for 5 minutes,
then placed in a 1% glutaraldehyde solution for 3 minutes,
and finally placed in 1% heparin sodium for 5 minutes. This
ensures that the heparin bonds ionically to the protamine,
which in turn combines covalently to the collagen, by the
action of glutaraldehyde. The graft was then placed in a 10%
neomycin solution for storage.
SVC replacement. A muscle-sparing right thoracotomy
through the fourth intercostal space was performed, and the
SVC was dissected free, from the level of the azygos vein to
the cavo-atrial junction. The length of the cava and its cir-
cumference at these 2 points and the mid-point between these
2 landmarks were measured.
Heparin sodium, 100 units/kg, was administered. Vascular
clamps were applied, and the SVC from the level of the azy-
gos vein to the cavo-atrial junction was replaced with SIS,
using an end-to-end anastomotic technique. In the first 7
piglets, we used 7-0 polypropylene, and in the last 4, we used
7-0 polydioxanone suture material.
Although the graft circumference exceeded that of the
cava, no longitudinal suture on the SIS was used, but the dis-
crepancy was made up by taking larger bites in the graft than
in the native cava.
After de-airing, the clamps were released, and the graft
length and maximal circumference were measured. The chest
was closed in layers; intercostal nerve blocks, using 0.25%
bupivacaine, were placed, and the animals were allowed to
wake up.
Perioperative antibiotic cover was continued for 48 hours,
with naxcillin. Except for analgesics, the only other medica-
tion the animals received was enoxaparin sodium, 15,000
units, subcutaneously for the first 5 days.
Three months after surgery, the animals were returned to
the operating room and anesthetized, by the same protocol. A
right internal jugular vein cutdown was performed; heparin
sodium 100 units/kg was administered, and a large-bore
catheter was placed in this vein, for the performance of a
cavogram. Iopamiro (60 mL) contrast material was injected,
and biplane angiograms were performed.
A midline sternotomy was performed, and the SVC was
dissected free of the surrounding tissues. Measurements of
the graft length and circumference at mid-point and the cir-
cumference of the native cava were taken.
The animals were then killed, with an injection of sodium
pentothal, 120 mg/kg, and potassium chloride, 20 mEq/kg.
The graft and the adjacent cava were excised and placed in a
buffered formaldehyde solution.
Sections were prepared for light and transmission electron
microscopy in a routine fashion, with representative tissues
fixed in 10% buffered formalin and 3% buffered glutaralde-
hyde, respectively.
Controls for this study were 4 pigs, in the same weight
range as the dead pigs, in which measurements of caval
length and diameter were taken, at the same levels.
Data analysis. Comparisons were made with an unpaired
(controls versus experimental animals) and a paired (mea-
surements at implantation and explantation for the experi-
mental group) t test, with a Dunn Sidak correction. All data
were expressed as a mean ± standard deviation.
Results
One piglet died immediately after the operation
when, during premature accidental extubation, it
became severely hypoxic during attempts at reintuba-
tion. The SVC graft was patent. Another piglet died 5
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Fig 2. Analysis of measurements of circumference and length of SIS grafts at implantation compared with
explantation. The explantation values are compared with control cavae between the azygos vein and the right atri-
um. The weight of the animals at implantation and explantation and the weight at explantation compared with
controls are shown in the far right columns.
weeks after operation after a septic episode, character-
ized by fever, rigors, and prostration, mandating
euthanasia. Pathologic examination showed its graft to
be patent and the intestinal anastomosis to be com-
pletely healed. It had significant hepatomegaly and a
large volume of turbid ascitic fluid, growing a Bacillus
species. Interestingly, this animal was housed together
with another piglet, in which similar symptoms devel-
oped, but which recovered after prompt institution of
antibiotic cover. However, its SIS graft, although com-
pletely incorporated and displaying the same macro-
scopic and microscopic features as all the others, grew
little and displayed an asymmetric central bulge.
Nine piglets survived to the end of the experiment,
between 10 and 14 weeks from the original operation.
Their weight increased from a mean of 10.3 ± 2.0 kg
before operation to a mean of 59.2 ± 16.7 kg after oper-
ation. This compared with a mean weight of 58.5 ± 6.6
kg in controls (Fig 2).
Their grafts were patent by cavogram, with a smooth,
slightly fusiform appearance, unchanged from immedi-
ately after the SVC replacement (Fig 3).
On measurement, the graft circumference increased
by 184%, from a mean circumference of 36.8 ± 4.4 mm
immediately after operation to a mean circumference of
61.4 ± 12.1 mm at late follow-up. This compared with
a mean caval circumference of 61.2 ± 6.4 mm in the
controls. The length of the graft increased by 147%,
from a mean of 9.9 ± 2.1 mm at implantation to a mean
of 15.8 ± 5.5 mm at explantation. This compares with
a mean of 23.8 ± 1.2 mm in the control animals (P =
.009). These data are summarized in Fig 2.
Pathologic examination. After preparation, the SIS
graft appears macroscopically as a thin, white tube,
approximately 0.1-mm thick. Hematoxylin and eosin
and van Gieson stains show it to consist of intestinal
submucosa, with an intact muscularis mucosa and
overlying stratum compactum (Fig 1, A and B). The
intestinal submucosa consists of paucicellular, dense
collagen, irregularly arranged, with prominent small
venules and arterioles, occasional lymphatic spaces,
and rare inflammatory cells (lymphocytes, histiocytes,
and mast cells). Small nerves and ganglion cells are
also present. The muscularis mucosa is a thin, orga-
nized bundle of smooth muscle cells; the stratum com-
pactum is a dense, acellular collagen structure, with a
small amount of elastic fibers.
Control SVC tissues exhibit features of normal large
veins, including an intact endothelium supported by
organized lamina, fibromuscular tissue, and elastic
fibers. The media of the SVC consists of organized
arrays of smooth muscle cells. Vasa vasorum are gen-
erally inconspicuous (Fig 1, C).
The explanted grafts were thicker than the original
SVC and densely adherent to the surrounding tissues,
from which they were relatively difficult to dissect.
The latter compromised efforts to evaluate organiza-
tion of a neo-adventitia in the graft. The luminal sur-
face of all the grafts appeared shiny, smooth, and free
of thrombus or irregularities. The suture lines were dis-
cernible as thin, slightly raised ridges in the animals
where a non-absorbable suture was used but appeared
smooth and flat where an absorbable suture was used.
Microscopically, the grafts were lined by a single,
continuous layer of flat or cuboidal endothelial cells,
overlying an organized, thick layer of well-vascular-
ized and variably cellular collagen. The endothelial
covering was already present in the graft explanted at 5
weeks. A rich capillary network was present across the
entire thickness of the graft. The suture lines were
inflamed, with a prominent foreign-body reaction.
Unlike normal SVC or pre-graft SIS, there was no evi-
dence of an organized vascular media, although smooth
muscle cells were focally admixed with fibrous ele-
ments near anastomoses and along small intramural
vessels. Elastic fibers were haphazardly arranged in the
subendothelial tissues (Fig 1, D).
On transmission electron microscopy, the luminal
surface was covered by a single layer of cuboidal cells
that rested on a continuous lamina. The cells had blunt,
interdigitating cell processes with occasional cell junc-
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Fig 3. An example of a cavogram shows the graft (g) 3
months after implantation, just before explantation. This was
unchanged from immediately after SVC replacement,
although the animal’s weight had increased fivefold.
tions. Pinocytosis was conspicuous on the luminal and
basolateral membranes. Weibel-Palade bodies were
identified (Fig 4). These ultrastructural features are
characteristic of endothelial cells.
Discussion
A vascular graft with growth properties is ideally
required in pediatric patients. This would obviate the
need for reoperations, required to match the graft
dimensions to those of a growing child, and if com-
pletely incorporated, would eliminate the risk of graft
infection.
So far, pericardium is the only material coming close
to meeting these requirements, although it has been
found to be prone to shrinkage, calcification, or alter-
natively aneurysm formation.8-10
Resourceful and inventive cardiovascular surgeons
have looked at different alternatives over the years. The
use of intestinal wall as a venous conduit was first
described by Matsumoto and associates2 in 1965. Since
then, other surgeons have also tried it, but the results
were quite variable. Lantz and colleagues5 developed a
new technique, using only the intestinal submucosa as
graft material. They reported excellent experimental
results using SIS to replace segments of veins and
arteries of both large and medium size.4-6 The grafts
remained patent as long as 5 years after implantation
and acquired an endothelial lining similar to the native
vessels. They became thicker, matching the thickness
of the replaced vessel, and developed a rich vascular
supply, which brought along smooth muscle cells and
connective tissue, the latter forming an adventitial
layer. The authors were able to demonstrate the same
good results using SIS xenografts that had been stored
for periods of up to 2 weeks.6 This led them to presume
that the SIS acts as a structural framework on which the
cellular organization takes place, leading eventually to
the formation of a new graft and resorbtion of the tem-
plate. This was demonstrated by the same group of
investigators by immunohistochemical analysis of the
remodeled tissue, suggesting that the SIS material was
degraded and resorbed over time.11 If the graft becomes
replaced by autologous tissue, it would be able to grow
at the same rate as the surrounding tissues, which was
our working premise. The circumferential growth of
the graft exceeded that in length. This may be related to
the short segment of cava replaced, making the 2 suture
lines relatively close together, with surrounding scar-
ring possibly impairing the growth to some extent, or
alternatively it may represent appropriate growth in
length for these hemodynamic conditions, given the
growth in width of the grafts, which kept the grafts the
same size as the surrounding cava. A different experi-
ment, replacing a longer segment of vessel, may be
able to better answer this question.
If SIS is only a structural framework and considering
the fact that the collagen molecule shows little vari-
ability among different species, a tissue bank for SIS
becomes a possibility, making this material available as
an off-the-shelf vascular substitute. The technique of
preparation and preservation of the SIS grafts is simple
and reproducible. Other investigators12,13 have devel-
oped other techniques aimed at biocompatibility, such
as endothelial cell seeding of Dacron grafts or prepara-
tion of an acellular matrix, using a multistep detergent-
enzymatic process. These techniques are more com-
plex, requiring specialized equipment and many
reagents and, in the case of the Dacron-based graft, do
not allow any growth to occur. 
Lantz and Badylak4,5 recommended aggressive
anticoagulation, using both aspirin and warfarin
(Coumadin) for a period of 8 weeks, time taken by the
graft to endothelialize because exposed collagen is very
thrombogenic. Even in systemically anticoagulated ani-
mals, SIS grafts used as microvascular grafts throm-
bosed within an hour after implantation.14 Our initial
experiments in piglets using the original technique
described by Lantz and Badylak5 led to a high rate of
early graft thrombosis. A study of the clotting and lytic
mechanisms in man and 7 mammalian species demon-
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Fig 4. Transmission electron microscopy of graft endotheli-
um. Cuboidal cells are supported along basement membranes
by basal lamina (bl). Cell junctions (j) connect apposed later-
al cell membranes. Delicate cell processes extend from api-
colateral surfaces. Pinocytic vesicles (p) are prominent along
all cell surfaces. Occasional Weibel-Palade bodies (wp) can
be identified. (Uranyl acetate/lead citrate stain; original mag-
nification · 6250.)
strated that overall, the pig had the most reactive blood
coagulation mechanisms, clotting the fastest and lysing
the slowest.15 This made a porcine model ideal for the
study of graft patency. We were able to avoid anticoag-
ulation (except for a daily dose of low-molecular
heparin for 5 days), by using a technique developed by
Miyata and colleagues,7 which achieves ionic bonding
of heparin to protamine, itself covalently bound to col-
lagen by the action of glutaraldehyde. The ionic
bonding permits slow release of the heparin and con-
tinuing antithrombogenicity while the graft becomes
endothelialized. Obviating the need for systemic anti-
coagulation represents a major advantage in infants and
children, given the difficulties in maintaining the anti-
coagulation regimen stable and minimizing patient dis-
comfort related to the frequent blood draws required by
children receiving warfarin therapy. 
The glutaraldehyde also may work to reduce the anti-
genicity of the collagen, making the graft less likely to
engender an immune response from the host. Collagen
is a weak antigen and represents an ideal matrix for the
ingrowth of host cells. Unlike the conventional glu-
taraldehyde-treated porcine valves, where collagen is
firmly crosslinked by the action of glutaraldehyde and
does not allow ingrowth of host cells into the graft, this
rapid protamine-glutaraldehyde-heparin soaking tech-
nique allows for a weaker covalent binding of the col-
lagen molecule to the glutaraldehyde through the prot-
amine molecule. This probably accounts for the
antithrombogenicity of the grafts and the relatively
rapid infiltration of the graft by host cells and endothe-
lialization. Even the graft explanted at 5 weeks already
displayed an endothelial lining.
Another concern related to the use of prosthetic mate-
rials in children is the high rate of calcification
observed in implanted homografts, xenografts, and
even autologous pericardium.9,16,17 We observed no
calcification in the grafts, despite using rapidly grow-
ing animals, in which the incidence of calcification is
expected to be high.
To date, we are aware of no grafts used in the pedi-
atric population that grow with the patient, which rep-
resents this graft’s greatest advantage over any other
grafts currently available. 
We are satisfied with the performance of the SIS graft
as a venous graft, and we feel that further research is
warranted in its use as a heterograft for vascular and
cardiac applications to best assess its potential as a car-
diovascular substitute in operations such as repair of
tetralogy of Fallot, pulmonary artery reconstruction,
Fontan procedures, or even valve replacements in
infants and children.
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Discussion
Dr John H. Kennedy (Cambridge, England). Crucial to
the issue of whether these cells revert to a primitive type, as,
for example, cultured renal cells do, and then will be truly
antithrombogenic, have you really proved that that is true in
the long term? I realize that in your fourth slide there was a
single cellular layer, and you have led us to believe that that
is an endothelial cell layer with all that implies, a failure of
rolling and sticking of white corpuscles, for example.
Dr Robotin-Johnson. Thank you for your question.
Badylak and Lantz conclusively demonstrated that the single
layer of cells lining the luminal surface of SIS grafts is indeed
an endothelial layer, by using scanning electron microscopy,
as well as immunocytochemistry with factor VIII–related
antigen and periodic acid–Schiff/alcian blue staining. To test
the lack of thrombogenicity of the grafts, we chose the pig as
an experimental model, as it has the most active clotting
mechanisms and the less-active lytic mechanisms of all the
usual experimental animals. The fact that we did not observe
any thrombus formation on any of the grafts seemed to us
very encouraging.
Dr Juan C. Chachques (Paris, France). A few years ago,
at Broussais Hospital in Paris we made a similar study using
autologous pericardium treated with glutaraldehyde. We
found similar results at 3 months, but at 1 year there is some
stenotic reaction at the level of the sutures. What is the
concentration of glutaraldehyde that you use in your study?
Because the problem is in the anastomosis of the graft in
long-term, which is the material that you use in the
anastomosis?
Dr Robotin-Johnson. I would like to answer the second
question first. We used 7-0 polypropylene suture (Prolene;
Ethicon, Inc, Somerville, NJ) in the first 7 animals. At the end
of the experiment, the suture lines were discernible as slightly
raised edges, but on histologic examination a foreign-body
reaction was quite evident. Subsequently, we changed to 7-0
polydioxanone (PDS; Ethicon) for the last 4 animals and
were gratified to observe that the suture lines were no longer
discernible with the naked eye, and although on histologic
sections the suture material was still present at 10 to 12
weeks, the amount of foreign-body reaction was much
reduced.
The method of graft preparation includes only a brief
immersion (3 minutes) in a diluted glutaraldehyde solution
(1% concentration), which differs from the standard method
of fixation for a heart valve, where tanning of the tissue
ensures covalent cross-linking of the collagen. Therefore no
ingrowth of host cells is possible, and this may be part of the
reason that these prosthetic materials fail in the long term, as
they never become incorporated into the host. Our
preparation ensures a covalent binding of collagen and
protamine. Heparin, which is subsequently added, becomes
ionically bound to the protamine and available for slow
release after implantation, while the graft becomes penetrated
by the host cells and endothelialized. As the graft remodels
and the ingrowth of the host cells transforms it into a
structure of the body’s own making, it becomes incorporated
and therefore less likely to engender a foreign body reaction
and fail.
Dr Fred A. Crawford, Jr (Charleston, SC). Did you
follow any of these animals longer than 90 days?
Dr Robotin-Johnson. Not as a part of this study, although
we kept an animal alive for 6 months. The graft preparation
method was somewhat different, so we did not include it
here. His graft was perfectly incorporated and showed
evidence of growth. Badylak and Lantz followed up their
dogs, in which they replaced carotid arteries with SIS grafts,
for up to 5 years. The grafts remained patent and without
evidence of intimal hyperplasia. As their method of graft
preparation was different, they had to rely on a vigorous
anticoagulation protocol, consisting of continuous heparin
infusion and warfarin sodium (Coumadin) for the time it took
for the grafts to become endothelialized.
Dr Edward D. Verrier (Seattle, Wash). I have 1 final
question. The use of vascular grafts in children in the low/
pressure SVC would be pretty unusual. It would be much
more common to use it as an arteriovenous graft, like a
Blalock shunt, or some type of right ventricular to pulmonary
artery graft. Have you used this in a model under higher
pressure where the potential for physical forces would be
more realistic to what you would see in a clinical situation?
Dr Robotin-Johnson. We used the SIS graft as a venous
substitute, as we wanted to answer questions related to the
potential thrombogenicity of these grafts, which would be
more evident in a low-pressure system, as well as the issue of
whether these grafts would grow, rather than simply “stretch”
under the influence of arterial pressure. I agree that to
broaden the scope of this material, other experiments would
be needed and we hope to be able to use them as pulmonary
artery substitutes and valve material.
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